|Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes|
AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ...
Nature 491 (7424), 399-405, 2012
|Whole genomes redefine the mutational landscape of pancreatic cancer|
N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ...
Nature 518 (7540), 495-501, 2015
|Genomic analyses identify molecular subtypes of pancreatic cancer|
P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ...
Nature 531 (7592), 47-52, 2016
|Whole-genome landscape of pancreatic neuroendocrine tumours|
A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ...
Nature 543 (7643), 65-71, 2017
|PINA v2. 0: mining interactome modules|
MJ Cowley, M Pinese, KS Kassahn, N Waddell, JV Pearson, ...
Nucleic acids research 40 (D1), D862-D865, 2012
|Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells|
F Hochgräfe, L Zhang, SA O'Toole, BC Browne, M Pinese, AP Cubas, ...
Cancer research 70 (22), 9391-9401, 2010
|Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling|
K Nones, N Waddell, S Song, AM Patch, D Miller, A Johns, J Wu, ...
International journal of cancer 135 (5), 1110-1118, 2014
|Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy|
BW Miller, JP Morton, M Pinese, G Saturno, NB Jamieson, E McGhee, ...
EMBO molecular medicine 7 (8), 1063-1076, 2015
|Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis|
C Vennin, VT Chin, SC Warren, MC Lucas, D Herrmann, A Magenau, ...
Science translational medicine 9 (384), 2017
|Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater|
DK Chang, NB Jamieson, AL Johns, CJ Scarlett, M Pajic, A Chou, ...
Journal of clinical oncology 31 (10), 1348-1356, 2013
|Hypermutation in pancreatic cancer|
JL Humphris, AM Patch, K Nones, PJ Bailey, AL Johns, S McKay, ...
Gastroenterology 152 (1), 68-74. e2, 2017
|Identification of functional networks of estrogen-and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer|
EA Musgrove, CM Sergio, S Loi, CK Inman, LR Anderson, MC Alles, ...
PloS one 3 (8), e2987, 2008
|Clinical and molecular characterization of HER2amplified-pancreatic cancer|
A Chou, N Waddell, MJ Cowley, AJ Gill, DK Chang, AM Patch, K Nones, ...
Genome medicine 5 (8), 78, 2013
|The effect of resveratrol on a cell model of human aging|
M Stefani, MA Markus, RCY Lin, M Pinese, IW Dawes, BJ Morris
Annals of the New York Academy of Sciences 1114 (1), 407-418, 2007
|Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer|
AV Biankin, JG Kench, EK Colvin, D Segara, CJ Scarlett, NQ Nguyen, ...
Gastroenterology 137 (2), 558-568. e11, 2009
|High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype|
SJ Zardawi, I Zardawi, CM McNeil, EKA Millar, D McLeod, AL Morey, ...
Histopathology 56 (3), 286-296, 2010
|qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles|
S Song, K Nones, D Miller, I Harliwong, KS Kassahn, M Pinese, M Pajic, ...
PloS one 7 (9), e45835, 2012
|Clinical and pathologic features of familial pancreatic cancer|
JL Humphris, AL Johns, SH Simpson, MJ Cowley, M Pajic, DK Chang, ...
Cancer 120 (23), 3669-3675, 2014
|Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction|
CJ Scarlett, EK Colvin, M Pinese, DK Chang, AL Morey, EA Musgrove, ...
PloS one 6 (10), e26088, 2011
|Somatic point mutation calling in low cellularity tumors|
KS Kassahn, O Holmes, K Nones, AM Patch, DK Miller, AN Christ, ...
PloS one 8 (11), e74380, 2013